Castleview Partners’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,235
Closed -$54.1K 909
2023
Q4
$54.1K Sell
3,235
-1,616
-33% -$26.1K 0.04% 286
2023
Q3
$80K Buy
4,851
+115
+2% +$2.03K 0.07% 199
2023
Q2
$85.8K Buy
4,736
+4,560
+2,591% +$78.5K 0.08% 197
2023
Q1
$3.3K Buy
176
+5
+3% +$88 ﹤0.01% 536
2022
Q4
$2.67K Buy
+171
New +$2.91K ﹤0.01% 498
2022
Q2
Sell
-6,763
Closed -$198K 766
2022
Q1
$198K Sell
6,763
-315,426
-98% -$9.41M 0.12% 164
2021
Q4
$8.27K Buy
+322,189
New +$12.9M 0.07% 108
2021
Q2
$290K Buy
+6,953
New +$264K 0.13% 171

Other funds holding BSTZ

Castleview Partners's BSTZ Position: Q1 2024 in Review

Castleview Partners sold out of BlackRock Science and Technology Term Trust (BSTZ) in Q1 2024, closing a stake of 3,235 shares — an estimated $54.1K sold.

Castleview Partners first reported a position in BSTZ in Q2 2021 and held it in 8 quarters. The position peaked at $290K in Q2 2021. 99 funds tracked by Wall St. Rank hold BSTZ as of Q1 2024.

  • Castleview Partners reported no remaining BlackRock Science and Technology Term Trust position as of Q1 2024 after selling out during the quarter.
  • Castleview Partners sold 3,235 BlackRock Science and Technology Term Trust shares in Q1 2024, an estimated $54.1K.
  • Castleview Partners first reported a position in BlackRock Science and Technology Term Trust in Q2 2021 and held it in 8 quarters.
  • Castleview Partners's BlackRock Science and Technology Term Trust position peaked at $290K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q1 2024.

Based on Castleview Partners's 13F filing for Q1 2024, filed 10 May 2024.